Skip to content
Pharma Observatory a Scientist.com platform

Organization (Industry)

ALPHABET INC.

ClinicalTrials.gov lists ALPHABET INC. as lead sponsor of 25 trials, counting the companies grouped under it.

US Other CIK 0001652044
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 4 Related companies not grouped here Related companies not grouped here 3 Disease areas Disease areas 23 Journals published in Journals published in 29 US granted patents US granted patents 1 Financing and grant events Financing and grant events 33 FDA import refusals FDA import refusals 1 Manufacturing and distribution sites Manufacturing and distribution sites 1 Companies grouped under this page Companies grouped under this page 4 Related companies not grouped here Related companies not grouped here 3 Disease areas Disease areas 23 Journals published in Journals published in 29 US granted patents US granted patents 1 Financing and grant events Financing and grant events 33 FDA import refusals FDA import refusals 1 Manufacturing and distribution sites Manufacturing and distribution sites 1

Rows recorded per section (log scale)

2 more sections with rows · 14 sections measured, none recorded

Logo {{Lejonta Jones is Owner]|original|Alphabet Inc.}}, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.

This page covers ALPHABET INC. and 4 companies with a profile grouped under it (a further 57 registry-linked records in the group have no profile): 25 lead-sponsored trials (0 its own, 25 in the grouped companies) and 10 legal-entity registrations (3 its own, 7 in the grouped companies).

Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.

Get the ALPHABET INC. report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (4)

Shown in this order: most lead trials first.

Companies grouped under this page
Company Country Lead trials Legal entities
Verily Life Sciences LLC (United States) US 11 1
Calico Life Sciences US 8 2
Fitbit (United States) US 6 1
GOOGLE LLC US 0 3

Counts companies with a profile grouped under this one. A further 57 registry-linked records in this group have no company profile and are not listed.

Disease areas (23)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Diabetes Mellitus 3
Diabetic Retinopathy 2
Anxiety Disorders 1
Aortic Valve Stenosis 1
Breast Neoplasms 1

Showing 5 of 23 disease areas.

Start your 14-day trial Email me all 23 disease areas as a PDF

Journals published in (29)

Shown in this order: most published in first.

Journals published in
Journal Publications
MMWR. Morbidity and mortality weekly report 3
Journal of medical Internet research 2
American heart journal 1
American journal of public health 1
BMC infectious diseases 1

Showing 5 of 29 journals.

Start your 14-day trial Email me all 29 journals as a PDF

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
31,451 8,158 2025-12-30

Financing and grant events (33)

Shown in this order: most recent first; amounts in US dollars.

Financing and grant events
Date Round type Amount Source
2026-08-07 Debt financing $24.9B Registered offering ceiling EDGAR offerings
2026-08-06 Other financing not disclosed EDGAR offerings
2026-08-06 Other financing not disclosed EDGAR offerings
2026-06-04 Follow-on offering $20.7B Registered offering ceiling EDGAR offerings
2026-06-04 Follow-on offering $9.63B Registered offering ceiling EDGAR offerings

Showing 5 of 33 events.

Start your 14-day trial Email me all 33 events as a PDF

FDA import refusals (1)

FDA import refusals
Refused import lines Latest refusal
1 2019-05-21

Manufacturing and distribution sites (1)

Manufacturing and distribution sites
Facility Location Regulators Member organization
FITBIT LLC 215 Fremont St, San Francisco, US FDA Fitbit (United States)

Organization relationships (5)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Duke University Co sponsors trial with 1
LSVT Global (United States) Co sponsors trial with 1
Amazon (United States) Co sponsors trial with 1
University of Illinois System Co sponsors trial with 1
Baseline Study LLC Co sponsors trial with 1

Latest dated events (31,502)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-08-07 Debt facility Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2026-08-06 Financing Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2026-08-06 Financing Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2026-06-04 Follow-on offering Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2026-06-04 Follow-on offering Funding rounds and grants (NIH RePORTER + SEC EDGAR)

Showing 5 of 31,502 events.

Start your 14-day trial Email me the first 50 events as a PDF

Not on this page

Checked, with nothing recorded for this organization: trials by start year as sponsor or collaborator, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.